ПочетнаBNTX • NASDAQ
add
BioNTech
Претходно закључено
105,56 $
Дневни опсег
105,60 $ - 114,48 $
Годишњи опсег
81,20 $ - 126,77 $
Тржишна вредност
29,58 млрд. USD
Просечна количина
1,16 мил.
Цена/зар.
-
Добит од дивиденди
-
Примарна размена
NASDAQ
Основни подаци
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes.
In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic. Wikipedia
Извршни директор: CEO
Датум оснивања
2008
Веб-сајт
Број запослених
6.772